STOCK TITAN

NXL Form 4: Leonard Osser and Spouse Report 1.62M Shares; 83,333 Acquired

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Nexalin Technology, Inc. (NXL) Form 4 shows Director Leonard Osser (with spouse Marilyn Elson) reported a non-derivative acquisition of 83,333 common shares on 09/29/2025 at a recorded price of $0. After the transaction the reporting parties beneficially own 1,618,577 shares, held directly with shared voting and dispositive power between Mr. Osser and Ms. Elson. The filing is a joint ownership Form 4 and is signed by both reporting persons.

Positive

  • Insider acquisition disclosed: 83,333 common shares acquired on 09/29/2025
  • Clear ownership reporting: Combined direct beneficial ownership quantified at 1,618,577 shares
  • Joint filing and signatures present: Form 4 signed by both reporting persons, indicating compliance with reporting rules

Negative

  • None.

Insights

TL;DR: Director purchase recorded; modest incremental stake relative to total reported holdings and no price paid is noted.

The Form 4 documents a purchase of 83,333 common shares by Director Leonard Osser, with the reporting structure showing joint ownership with spouse Marilyn Elson. The filing records the transaction price as $0 and shows combined direct beneficial ownership of 1,618,577 shares after the trade. For investors, this transaction updates insider stake levels but does not on its face provide valuation context or indicate change in control. The absence of derivative activity and the direct ownership form simplify the ownership picture.

TL;DR: Governance update confirms insider ownership and shared voting power; filing appears routine.

The report clarifies that voting and dispositive powers over the reported shares are shared between Mr. Osser and Ms. Elson, and the Form 4 is filed as a joint ownership disclosure. Signatures from both reporting persons are present, satisfying Section 16 reporting formalities. The filing contains no derivative grants, option exercises, or departures that would signal governance shifts.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
OSSER LEONARD

(Last) (First) (Middle)
32 CAMLET COURT

(Street)
ROSELAND NJ 07068

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Nexalin Technology, Inc. [ NXL ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director X 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
09/29/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
X Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/29/2025 A 83,333 A $0 1,618,577(1) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
1. Name and Address of Reporting Person*
OSSER LEONARD

(Last) (First) (Middle)
32 CAMLET COURT

(Street)
ROSELAND NJ 07068

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
Elson Marilyn

(Last) (First) (Middle)
32 CAMLET COURT

(Street)
ROSELAND NJ 07068

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director 10% Owner
Officer (give title below) X Other (specify below)
Spouse
Explanation of Responses:
1. Includes shares that Reporting Person owns with spouse Leonard Osser and for which Reporting Person has shared voting and dispositive power with spouse. Form 4 filed as joint ownership filing
/s/ Leonard Osser Name: Leonard Osser 09/30/2025
/s/ Marilyn Elson Name: Marilyn Elson 09/30/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction was reported on the Form 4 for Nexalin Technology (NXL)?

The Form 4 reports a non-derivative acquisition of 83,333 common shares on 09/29/2025.

Who filed the Form 4 for NXL and what are their relationships to the company?

The filing was made by Director Leonard Osser and spouse Marilyn Elson; Mr. Osser is a director and both report shared voting and dispositive power.

How many Nexalin shares do the reporting persons own after the transaction?

Following the reported transaction they beneficially own 1,618,577 shares (direct ownership).

What price was recorded for the shares acquired in the Form 4?

The transaction is recorded at a price of $0 in the Form 4.

Was any derivative security activity (options, warrants) reported on this Form 4?

No derivative securities were reported; Table II is empty for derivative activity in this filing.
Nexalin Tech

NASDAQ:NXL

NXL Rankings

NXL Latest News

NXL Latest SEC Filings

NXL Stock Data

12.87M
16.08M
14.34%
7.53%
3.5%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States
HOUSTON